The Effect of the ET-1 Receptor Antagonist, Bosentan, on Patients With Poorly Controlled Asthma: A 17 Week, Double-blind, Placebo-Controlled Crossover Pilot Study

Authors

Timothy Coyle MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

10-2011

Volume

140

Issue

4

Published In/Presented At

10.1378/chest.1114871

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine

Document Type

Article